ISSN: 2153-0645
Journal of Pharmacogenomics & Pharmacoproteomics
Open Access
Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)Recommended Conferences
- 4th International Conference on
Drug Discovery
,
Designing
and
Development
June 27-28, 2018 Vancouver, Canada - International Conference And Exhibition on
Drug Safety
& Pharmacovigilance
August 29-30, 2018 Toronto, Canada - 18th World
Pharma
Congress
October 18-19, 2018 Warsaw, Poland
Recommended Journals
Relevant Topics
- Applications of Bioinformatics
- Bioactive Compound
- Bioinformatics Algorithms
- Bioinformatics Databases
- Bioinformatics Tools
- Cancer Pharmacogenomics
- Cancer Proteomics
- Cellular Medicine
- Clinical Pharmacogenomics
- Clinical Proteomics
- Cluster analysis
- Comparative genomics
- Comparative proteomics
- Computational drug design
- Current Proteomics
- Data algorithms
- Data mining applications in genomics
- Data mining applications in proteomics
- Data mining in drug discovery
- Data mining tools
- Data modelling and intellegence
- Data warehousing
- Drug Dosage Formulations
- Drug Toxicity and Efficacy
- Epigenomic studies
- Epigenomics
- Gene Therapy
- Gene polymorphism
- Genetic Engineering in Medicine
- Genome annotation
- Genomic Medicine
- Genomic Targets
- Genomic data mining
- Genomic data warehousing
- Human Molecular Genetics
- Human Proteome Project Applications
- Immune Disorders
- Individualized Medicine
- Mapping of genomes
- Mass Spectrometry in Proteomics
- Medicinal Biotechnology
- Meta genomics
- Metabolomics
- Microarray Proteomics
- Molecular Basis of Cancer
- Molecular Basis of Obesity
- Molecular Diagnosis
- Molecular Genetic Test
- Molecular Medicine
- Molecular and Cellular Proteomics
- Nuclear Medicine
- Pathology and Molecular Medicine
- Personalized Medicine
- Personalized Medicine Studies
- Pharmacoeconomics in Drug Development
- Pharmacogenetics
- Pharmacogenomic Biomarker
- Pharmacogenomics Applications
- Pharmacogenomics Future Medicine
- Pharmacogenomics and Personalized Medicine
- Pharmacogenomics for Patient Care
- Pharmacoproteomics in Drug development
- Protein Sequence Analysis
- Proteogenomics
- Proteome Profiling
- Proteomic Analysis
- Proteomic Biomarkers
- Proteomics Clinical Applications
- Proteomics Research
- Proteomics Science
- Proteomics and Pharmacodynamics
- Proteomics data warehousing
- Python for Bioinformatics
- Quantitative Proteomics
- Statistical data mining
- Translational Medicine
Meriem Samia Aberkane |
||
| Laboratoire de Génétique moléculaire et Cellulaire, Université des Sciences et de la Technologie d’Oran -Mohamed Boudiaf- (USTOMB), Oran, Algeria | ||
| Biography | ||
Meriem Samia Aberkane is from Laboratoire de Génétique moléculaire et Cellulaire, Université des Sciences et de la Technologie d’Oran -Mohamed Boudiaf- (USTOMB), Oran, Algeria |
||
| Research Interest | ||
Biotechnology, Molecular Biology, Genetics |
||
| Publications | ||
|
Factor 8 Gene Mutations and Risk of Inhibitor Development in Hemophilia A Algerian Patients Faouzia Zemani-Fodil, Meriem Abdi, Mostefa Fodil, Meriem Samia Aberkane, Naima Mesli, Mohamed Belazaar, Malika Mehalhal, Yasmina Rahal, Hadj Touhami, Nadhira Saidi-Mehtar and Abdallah Boudjema Research Article: J Pharmacogenomics Pharmacoproteomics 2014, 5:1 |
||
Global Speakers in the subjectGlobal Experts in the subject |
||
